- Trials with a EudraCT protocol (35)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
35 result(s) found for: LogMAR chart.
Displaying page 1 of 2.
EudraCT Number: 2006-001386-42 | Sponsor Protocol Number: REC no:06/Q0403/25 | Start Date*: 2006-07-06 |
Sponsor Name:Imperial College | ||
Full Title: The timing of intra-vitreal (4mg) triamcinolone acetonide, in addition to verteporfin photodynamic therapy for choroidal neovascularisation, in age-related macular degeneration: a prospective rando... | ||
Medical condition: Submacular choroidal neovascularisation in Age-related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004405-16 | Sponsor Protocol Number: SNT-IV-005 | Start Date*: 2016-03-16 | |||||||||||
Sponsor Name:Santhera Pharmaceuticals (Switzerland) Limited | |||||||||||||
Full Title: External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) | |||||||||||||
Medical condition: Leber’s Hereditary Optic Neuropathy / LHON is a maternally inherited loss of vision due to atrophy of the optic nerve. It typically presents in young adults, mostly men, as painless acute or subacu... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) BE (Completed) PT (Completed) ES (Completed) BG (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001266-26 | Sponsor Protocol Number: GS-LHON-CLIN-03B | Start Date*: 2016-01-21 |
Sponsor Name:GENSIGHT-BIOLOGICS | ||
Full Title: A Randomized, Double-Masked, Sham-Controlled, Pivotal Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 (rAAV2/2-ND4) in Subjects Affected for more than 6 months a... | ||
Medical condition: Leber Hereditary Optic Neuropathy due to mutations in the mitochondrial NADH Dehydrogenase 4 gene | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000397-45 | Sponsor Protocol Number: OY060301 | Start Date*: 2005-06-02 |
Sponsor Name:Queen's Medical centre | ||
Full Title: Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser Treatment | ||
Medical condition: Diabetic macular oedema affecting vision and refractory to laser treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023216-14 | Sponsor Protocol Number: HP-AM2-001 | Start Date*: 2011-03-15 | ||||||||||||||||||||||||||
Sponsor Name:Hermo Pharma Ltd | ||||||||||||||||||||||||||||
Full Title: A Phase II, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of 10 Weeks Treatment with Fluoxetine 20 mg and Computer Software-Based Training in Adult Patients with Amblyopia | ||||||||||||||||||||||||||||
Medical condition: treatment of adult amblyopia - amblyopia due to myopic or hyperopic anisometropia, or, congenital esotropia. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FI (Completed) EE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001265-11 | Sponsor Protocol Number: GS-LHON-CLIN-03A | Start Date*: 2016-01-21 |
Sponsor Name:GENSIGHT-BIOLOGICS | ||
Full Title: A Randomized, Double-Masked, Sham-Controlled, Pivotal Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 (rAAV2/2-ND4) in Subjects Affected for 6 Months or Less by... | ||
Medical condition: Leber Hereditary Optic Neuropathy due to mutations in the mitochondrial NADH Dehydrogenase 4 gene | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-001843-20 | Sponsor Protocol Number: KETOR001 | Start Date*: 2008-10-01 |
Sponsor Name:Frimley Park Hospital | ||
Full Title: Prevention of pseudophakic cystoid macula oedema with pre- and postoperative ketorolac | ||
Medical condition: cystoid macula oedema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005450-71 | Sponsor Protocol Number: LUZVT06 | Start Date*: 2007-06-29 |
Sponsor Name:Augenklinik der LMU München | ||
Full Title: INTRAVITREAL RANIBIZUMAB THERAPY FOR MACULA EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION (RAVO) | ||
Medical condition: Macula edema resulting from central retinal vein occlusion in the eye | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002153-11 | Sponsor Protocol Number: GS-LHON-CLIN-06 | Start Date*: 2018-02-12 | |||||||||||
Sponsor Name:GENSIGHT BIOLOGICS | |||||||||||||
Full Title: Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials | |||||||||||||
Medical condition: Leber Hereditary Optic Neuropathy due to mutations in the mitochondrial NADH Dehydrogenase 4 gene | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003976-42 | Sponsor Protocol Number: OT_101_001 | Start Date*: Information not available in EudraCT |
Sponsor Name:Ocumension (Hong Kong) Limited | ||
Full Title: A phase III, randomized, double-masked, placebo controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine 0.01%) in treating the progression of myopia in pediatri... | ||
Medical condition: myopia | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) SK (Trial now transitioned) IE (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001215-37 | Sponsor Protocol Number: RG_16_211 | Start Date*: 2018-03-19 |
Sponsor Name:University of Birmingham | ||
Full Title: A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome | ||
Medical condition: Wolfram syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001281-33 | Sponsor Protocol Number: RGHT000449 | Start Date*: 2007-07-09 | |||||||||||
Sponsor Name:Belfast Health and Social Care Trust [...] | |||||||||||||
Full Title: A randomised control trial of alternative treatments to Inhibit VEGf in Age-related choroidal Neovascularisation(IVAN) | |||||||||||||
Medical condition: Choroidal neovascularisation in age related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007476-19 | Sponsor Protocol Number: OP/2008/2980 | Start Date*: 2009-09-24 |
Sponsor Name:University Hospitals Bristol NHS Trust | ||
Full Title: A prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes. | ||
Medical condition: idiopathic and inflammatory choroidal neovascular membranes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005556-25 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.2 | Start Date*: 2015-05-11 |
Sponsor Name:Investigacion Independiente | ||
Full Title: Open extension study for patients with age related macula degeneration who participated in the Fase IV-II clinical trial randomized, simulatedcontrolled treatment to evaluate safety and efficacy o... | ||
Medical condition: Aged related macula degeneration (ARMD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003653-16 | Sponsor Protocol Number: S62092 | Start Date*: 2019-03-21 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: Abatacept in patients with Birdshot HLA A29 uveitis: A Phase II Prospective 0pen Label Interventional Proof-of-Concept Study | |||||||||||||
Medical condition: Birdshot Uveitis HLA A29 retinochoroiditis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004108-23 | Sponsor Protocol Number: 17097AB-AS | Start Date*: 2018-10-09 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Low-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo controlled randomised trial in the United Kingdom (CHAMP UK) | ||
Medical condition: Myopia | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005694-31 | Sponsor Protocol Number: 2012/ADE002 | Start Date*: 2013-07-05 | |||||||||||
Sponsor Name:Adenovir Pharma AB | |||||||||||||
Full Title: Evaluation of the Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Acute Phase Adenoviral-Induced Epidemic Keratoconjunctivitis (EKC). A Randomised, Double-Masked, Placebo-Controlled, Mult... | |||||||||||||
Medical condition: Acute phase Adenoviral-induced Epidemic Keratoconjunctivitis, EKC | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003229-17 | Sponsor Protocol Number: Protocol1 | Start Date*: 2014-10-06 |
Sponsor Name:Inst of OPhthalmology, Lund University | ||
Full Title: To compare the effect of Eylea given every other month after three injections to treatment with a gradual extension intervals. and examine retinal function with electroretinography (ERG) in patient... | ||
Medical condition: To evaluate if Aflibercept given every eighth week from start after an initial loading dose in age-related macular degeneration (AMD), is as effective as dosing as "Treat and extend" where treati... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003215-63 | Sponsor Protocol Number: 69HCL19_0032 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Hospices Civils de Lyon - Direction de la Recherche Clinique et de l'Innovation | |||||||||||||
Full Title: Cultured Autologous Oral Mucosa Epithelial sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency - FEMJA for « Feuillet Epithélial de Muqueuse Jugale Autologue » | |||||||||||||
Medical condition: Bilateral Limbal Stem Cell Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001812-36 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.3 | Start Date*: 2015-08-11 |
Sponsor Name:Dr. Pedro Cuevas Sanchez (Investigacion Independiente) | ||
Full Title: Extension study for the follow up of patients with age related macula degeneration who participated in the Fase IV-II clinical trial randomized, simulated controlled treatment to evaluate safety an... | ||
Medical condition: Aged related macula degeneration (ARMD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
